NCT04691232View on ClinicalTrials.gov

Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

April 12, 2023

Study Completion Date

May 22, 2023

Conditions
Ulcerative ColitisAutoimmune Diseases
Interventions
BIOLOGICAL

Regulatory T cells

Autologous, ex vivo expanded, regulatory T cells

Trial Locations (1)

91054

University of Erlangen-Nürnberg Medical School, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT04691232 - Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis | Biotech Hunter | Biotech Hunter